Considerable Costs Incurred in Response to Single Measles Cases

Share this content:
Considerable Costs Incurred in Response to Single Measles Cases
Considerable Costs Incurred in Response to Single Measles Cases

MONDAY, Nov. 27, 2017 (HealthDay News) -- Single measles cases trigger coordinated public health action that is associated with considerable costs, according to research published in the Nov. 24 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Grace E. Marx, M.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues identified two unrelated measles cases in the Denver area during July 2016 to January 2017 after patients traveled to countries with endemic measles transmission. Each case resulted in multiple exposures at health care facilities and public venues, activating an immediate and complex local and state public health agency response. The authors examined the economic burden associated with investigating and responding to single measles cases.

The researchers did not identify secondary cases of measles in either investigation. In the first case, post-exposure prophylaxis was administered to 31 contacts, while no contacts were eligible in the second case due to a delay in diagnosis. In the first and second cases, the public health costs of disease investigation were estimated at $49,769 and $18,423, respectively.

"Single measles cases prompted coordinated public health action and were costly and resource-intensive for local public health agencies," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

FDA OKs Nucala for Eosinophilic Granulomatosis With Polyangiitis

First drug to be approved for rare autoimmune disease that leads to vasculitis

Findings Support Individualized Glycemic Control in T2DM

Findings Support Individualized Glycemic Control in T2DM

Approach saved $13,547/patient vs uniform intensive control, with lower medication costs

Atherosclerosis ID'd in Many Without CV Risk Factors

Atherosclerosis ID'd in Many Without CV Risk Factors

LDL-C independently associated with the presence and extent of atherosclerosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »